Aster DM Healthcare debuted on the National Stock Exchange of India and the Bombay Stock Exchange in February with a US$153 million initial public offering (IPO).
“It is uncommon for an Indian-listed company to primarily operate outside of India,” Latham & Watkins’ Singapore partner and India practice head Rajiv Gupta told India Business Law Journal.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.